𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports

✍ Scribed by Takehito Shukuya; Toshiaki Takahashi; Rieko Kaira; Akira Ono; Yukiko Nakamura; Asuka Tsuya; Hirotsugu Kenmotsu; Tateaki Naito; Kyoichi Kaira; Haruyasu Murakami; Masahiro Endo; Kazuhisa Takahashi; Nobuyuki Yamamoto


Book ID
108587028
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
232 KB
Volume
102
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The impact of epidermal growth factor re
✍ Shuji Ichihara; Shinichi Toyooka; Yoshiro Fujiwara; Katsuyuki Hotta; Hisayuki Sh πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 403 KB πŸ‘ 2 views

## Abstract We investigated the relationships between genetic factors and clinical outcome in Japanese non‐small‐cell lung cancer (NSCLC) patients treated with gefitinib. Ninety‐eight NSCLC patients who had been treated with gefitinib, were screened for mutations in epidermal growth factor receptor

Comparative analysis of epidermal growth
✍ Takashi Sone; Kazuo Kasahara; Hideharu Kimura; Kazuto Nishio; Masayuki Mizuguchi πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 235 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Because the investigation of epidermal growth factor receptor gene (__EGFR__) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated __EGFR__ mutations and gene amplification in biopsy specimens from Japanese patients wi